Spatial distortion correction and crystal identification for MRI-compatible position-sensitive avalanche photodiode-based PET scanners.

A. J. Chaudhari, Y. Wu and S. R. Cherry are with the Department of Biomedical Engineering, University of California-Davis, Davis, CA 95616, USA (Email: ).
IEEE Transactions on Nuclear Science (Impact Factor: 1.22). 06/2009; 56(3):549-556. DOI: 10.1109/TNS.2009.2018841
Source: IEEE Xplore

ABSTRACT Position-sensitive avalanche photodiodes (PSAPDs) are gaining widespread acceptance in modern PET scanner designs, and owing to their relative insensitivity to magnetic fields, especially in those that are MRI-compatible. Flood histograms in PET scanners are used to determine the crystal of annihilation photon interaction and hence, for detector characterization and routine quality control. For PET detectors that use PSAPDs, flood histograms show a characteristic pincushion distortion when Anger logic is used for event positioning. A small rotation in the flood histogram is also observed when the detectors are placed in a magnetic field. We first present a general purpose automatic method for spatial distortion correction for flood histograms of PSAPD-based PET detectors when placed both inside and outside a MRI scanner. Analytical formulae derived for this scheme are based on a hybrid approach that combines desirable properties from two existing event positioning schemes. The rotation of the flood histogram due to the magnetic field is determined iteratively and is accounted for in the scheme. We then provide implementation details of a method for crystal identification we have previously proposed and evaluate it for cases when the PET detectors are both outside and in a magnetic field. In this scheme, Fourier analysis is used to generate a lower-order spatial approximation of the distortion-corrected PSAPD flood histogram, which we call the 'template'. The template is then registered to the flood histogram using a diffeomorphic iterative intensity-based warping scheme. The calculated deformation field is then applied to the segmentation of the template to obtain a segmentation of the flood histogram. A manual correction tool is also developed for exceptional cases. We present a quantitative assessment of the proposed distortion correction scheme and crystal identification method against conventional methods. Our results indicate that our proposed methods lead to a large reduction in manual labor and indeed can routinely be used for calibration and characterization studies in MRI-compatible PET scanners based on PSAPDs.

  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper first results of a new detector concept called Sensitivity encoded Silicon Photomultiplier (SeSP) that has been invented in 2011 has been presented. It combines the advantages of sensitivity encoding and SiPM technology without changing the manufacturing process of the devices.
    Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 2012 IEEE; 01/2012
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Silicon Drift Detector (SDD) has been successfully employed as scintillation photodetector in the development of new gamma-ray detectors, with particular application in the field of medical imaging. In addition to other advantages, the SDD may offer a good insensitivity to magnetic fields, which represents an important feature for the use of this device in combination with MRI (Magnetic Resonance Imaging). In this work, we carry out a study about the behavior of a SDD when operated inside a MRI apparatus. We have evaluated the performances of a single detection unit which is the basic component for the realization of future imagers composed by arrays of several SDDs. The main effects on the charge collection in a SDD due to the presence of a constant magnetic field was simulated and experimentally tested on a prototype. Moreover, the effects of both gradient fields and radiofrequency signals on the device and related electronics were evaluated. Tests were also performed to verify that the presence of the detection system did not significantly perturb the images acquired with the MRI system. The experimental characterization was undertaken with a simplified detection system operated in simultaneous acquisition with a commercial MRI scanner operating at 7 T.
    IEEE Transactions on Nuclear Science 05/2011; · 1.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Response Evaluation Criteria in Solid Tumors (RECIST) and World Health Organization (WHO) Criteria have been traditionally used for the evaluation of therapeutic response to chemotherapeutic treatment regimens. They determine anatomic criteria for patients response to anti-cancer therapy based on morphological measurements of each target lesion. While this assessment is justified for cytotoxic (chemotherapeutic) drugs, it is now recognized that morphological imaging protocols are poorly suited to the evaluation of the efficacy of novel signal transduction inhibitors (STIs) which exhibit cytostatic rather than cytotoxic properties. New imaging technologies are now designed to evaluate, in a functional manner, modifications in tumor metabolic activity, cellularity, and vascularization before a reduction in tumor volume can be detected. Introduction of physiological imaging end-points, derived from dynamic contrast-enhanced (DCE) imaging protocols--including magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound (US)--allow for early assessment of disruption in tumor perfusion and permeability for targeted anti-angiogenic agents. Diffusion-weighted MRI (DWI) provides another physiological imaging end-point since tumor necrosis and cellularity are seen early in response to anti-angiogenic treatment. Changes in glucose and phospholipid turnover, based on metabolic MRI and positron emission tomography (PET), provide reliable markers for therapeutic response to novel receptor-targeting agents. Finally, novel molecular imaging techniques of protein and gene expression have been developed in animal models followed by a successful human application for gene therapy-based protocols.
    Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 06/2011; 14(4-5):224-35. · 12.58 Impact Factor

Full-text (5 Sources)

Available from
May 15, 2014